NASDAQ:FUSN
Fusion Pharmaceuticals Inc.
- Stock
Last Close
21.52
03/06 20:00
Market Cap
1.83B
Beta: −1.15
Volume Today
6.08M
Avg: 377.71K
PE Ratio
−8.03
PFCF: −8.88
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
net income | -6.26M - | -11.65M 86.02% | -16.19M 38.94% | -78.33M 383.87% | -81.05M 3.46% | -87.61M 8.10% | -94.90M 8.32% | |
depreciation and amortization | 23K - | 114K 395.65% | 290K 154.39% | 482K 66.21% | 634K 31.54% | 909K 43.38% | 1.34M 47.96% | |
deferred income tax | 34K - | -19K 155.88% | -59K 210.53% | -576K 876.27% | -991K 72.05% | -3.16M 219.07% | 845K 126.72% | |
stock based compensation | 112K - | 556K 396.43% | 618K 11.15% | 3.37M 444.98% | 8.60M 155.43% | 10.84M 26.05% | 12.44M 14.75% | |
change in working capital | 703K - | -572K 181.37% | 3.08M 639.34% | 5.74M 85.93% | -14.60M 354.45% | 3.66M 125.08% | -667K 118.22% | |
accounts receivables | -357K - | 296K 182.91% | 54K 81.76% | |||||
inventory | -12.09M - | |||||||
accounts payables | 589K - | -381K 164.69% | 479K 225.72% | 2.56M 434.03% | -1.18M 146.25% | 400K 133.81% | -721K 280.25% | |
other working capital | 114K - | -191K 267.54% | 2.61M 1,464.40% | 3.18M 21.95% | -962K 130.27% | 2.96M 408.11% | 667K 77.50% | |
other non cash items | -733K - | 1.71M 332.88% | -1.44M 184.07% | 39.56M 2,856.52% | 11.66M 70.53% | 2.08M 82.11% | -1.54M 173.81% | |
net cash provided by operating activities | -6.13M - | -9.87M 61.08% | -13.69M 38.76% | -29.77M 117.44% | -75.74M 154.44% | -73.28M 3.25% | -81.80M 11.64% | |
investments in property plant and equipment | -96K - | -1.12M 1,069.79% | -456K 59.39% | -1.12M 146.27% | -1.49M 32.77% | -2.14M 43.66% | -3.89M 81.61% | |
acquisitions net | -9.70M - | -39.27M 304.79% | -25.23M 35.75% | |||||
purchases of investments | -219.03M - | -172.47M 21.26% | -165.16M 4.24% | -230.57M 39.61% | ||||
sales maturities of investments | 9.70M - | 211.73M 2,082.82% | 190.38M 10.08% | 191.70M 0.69% | ||||
other investing activites | 9.70M - | 39.27M 304.79% | 25.23M 35.75% | |||||
net cash used for investing activites | -96K - | -1.12M 1,069.79% | -456K 59.39% | -210.45M 46,051.97% | 37.77M 117.95% | 23.09M 38.88% | -42.76M 285.23% | |
debt repayment | -52.19M - | -72.40M 38.73% | -34.69M - | |||||
common stock issued | 197.63M - | 347K 99.82% | 5.81M 1,575.50% | |||||
common stock repurchased | -72.40M - | 8.92M 112.33% | 1.28M 85.60% | |||||
dividends paid | -1.38M - | -34.69M - | ||||||
other financing activites | 27.17M - | 18.37M 32.39% | 52.19M 184.10% | 214.06M 310.18% | -8.92M 104.17% | 103.02M 1,254.42% | 142.01M 37.84% | |
net cash used provided by financing activities | 27.17M - | 18.37M 32.39% | 52.19M 184.10% | 265.51M 408.76% | 347K 99.87% | 40.73M 11,638.62% | 142.01M 248.63% | |
effect of forex changes on cash | ||||||||
net change in cash | 20.95M - | 7.38M 64.77% | 38.04M 415.46% | 25.29M 33.53% | -37.62M 248.77% | -9.46M 74.86% | 17.44M 284.44% | |
cash at beginning of period | 750K - | 21.70M 2,793.33% | 29.08M 34.01% | 67.12M 130.81% | 92.41M 37.67% | 54.79M 40.71% | 45.33M 17.26% | |
cash at end of period | 21.70M - | 29.08M 34.01% | 67.12M 130.81% | 92.41M 37.67% | 54.79M 40.71% | 45.33M 17.26% | 62.77M 38.47% | |
operating cash flow | -6.13M - | -9.87M 61.08% | -13.69M 38.76% | -29.77M 117.44% | -75.74M 154.44% | -73.28M 3.25% | -81.80M 11.64% | |
capital expenditure | -96K - | -1.12M 1,069.79% | -456K 59.39% | -1.12M 146.27% | -1.49M 32.77% | -2.14M 43.66% | -3.89M 81.61% | |
free cash flow | -6.22M - | -10.99M 76.64% | -14.15M 28.73% | -30.89M 118.37% | -77.23M 150.02% | -75.42M 2.35% | -85.69M 13.62% |
All numbers in USD (except ratios and percentages)